6,333
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors

ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, , , , & ORCID Icon show all
Pages 123-135 | Received 28 Oct 2022, Accepted 05 Jan 2023, Published online: 06 Mar 2023